Tag: Evolocumab

Globally, high cholesterol is responsible for an estimated 4.4 million deaths each year. For patients needing significant reduction of LDL cholesterol, understanding treatment options is critical. So, **how is Evolocumab administered** to manage this risk?

According to clinical trial data, injection site reactions were experienced by a small percentage of patients, emphasizing the importance of proper injection technique for comfort and effectiveness. Here is a comprehensive guide on **how to inj repatha** safely and confidently at home.

PCSK9 inhibitors can significantly lower "bad" low-density lipoprotein (LDL) cholesterol by 50% to 70%, offering a powerful treatment option for patients who cannot achieve their target levels with statins alone. These advanced medications target a specific protein in the liver to increase cholesterol clearance from the bloodstream. This guide explores the different drugs that are PCSK9 inhibitors, their mechanisms, and their role in modern cardiovascular care.

As of mid-2025, pharmaceutical manufacturer Amgen is phasing out certain delivery systems for its cholesterol-lowering medication, Repatha, leaving many patients to wonder: **Why are they discontinuing Repatha?** This decision specifically affects the Pushtronex System and standard prefilled syringes, but it is not due to any safety or efficacy issues with the drug itself.